Marketing & Strategy
Reimagine the ‘new normal’ of HCP engagement

Marketing & Strategy: The greatest danger in times of turbulence is not the turbulence, it is to act with yesterday’s logic. Peter Drucker
As a result of COVID-19, the traditional HCP customer engagement models are evolving into a ‘new normal’.
In a recent interview with Health Industry Hub, Ross Murray, Strategic Partnership Director at Australian Doctor Group (ADG), discussed the emerging trends in customer engagement, the future of face-to-face HCP interactions and the impact of digital marketing and personalised content delivery on brand management.
- What are the key emerging trends impacting clinicians and how does this influence pharma’s marketing and commercial engagement with HCPs?
- How can companies bridge the gap between f2f and virtual engagement to achieve a sustainable competitive advantage in the ‘new normal’?
- How are innovative brands leveraging data and analytics to understand where digital marketing is influencing HCP behaviour in order to complement field force activity and drive ROI?
- What are the key barriers to delivering and optimising content in an agile manner to meet clinician needs?
- How does digital unlock more value from pharma marketing investments?
News & Trends - MedTech & Diagnostics

Healthcare sector’s political donations: What to expect ahead of the federal election
Ahead of the upcoming federal election, attention turns to the financial contributions to major political parties. The Australian Electoral Commission’s […]
MoreNews & Trends - Pharmaceuticals

‘Underinvestment in gynae cancer has left critical gaps,’ says ANZGOG Chair
Ovarian cancer is the deadliest women’s cancer, with the latest statistics revealing a five-year survival rate of just 49%. Alarmingly, […]
MoreNews & Trends - MedTech & Diagnostics

Labor’s one-off funding a band aid for public hospitals while private sector left in limbo
The Federal Government has committed a one-off funding boost of $1.7 billion to public hospitals under a one-year extension to […]
MoreNews & Trends - Pharmaceuticals

AI-powered test to reshape use of hormone therapy in prostate cancer
Australian researchers are pioneering the use of artificial intelligence (AI) to enhance decision-making in prostate cancer treatment, specifically focusing on […]
More